100
Participants
Start Date
September 14, 2020
Primary Completion Date
February 28, 2027
Study Completion Date
May 30, 2027
ADI-PEG 20
Investigational Medicine
Temozolomide
Radiotherapy and TMZ are standard front-line therapy for newly diagnosed GBM.
Placebo
Investigational Medicine
Seoul National University Bundang Hospital, Gyeonggi-do
Chonnam National University Hwasun Hospital, Hwasun-gun
National Taiwan University Hospital, Taipei
Chang Gung-Medical Foundation-Keelung (CGMF-KL), Keelung
Mackay Memorial Hospital-Tamsui Branch, New Taipei City
Chang Gung Memorial Hospital, Linkou Branch, Taoyuan District
Chang Gung Medical Foundation-Kaohsiung, Kaohsiung City
Seoul National University Hospital, Seoul
Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul
Severance Hospital Yonsei University, Seoul
Lead Sponsor
Polaris Group
INDUSTRY